WebDisclosure WebDisclosure
Basculer en Français
10916 Companies
238198 Keywords
167076 Articles
127998 Press releases
Headlines Articles Press releases Emmecell Remove
  1. Home
  2. Companies
  3. Emmecell
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/30/2024 at 13:05, 2 years 4 months ago

    Emmecell Completes Final Cell Therapy Dosing in U.S. Clinical Trial for Corneal Edema

    Clinical Trial Cell Therapy Emmecell Corneal Edema Non-surgical Treatment
  • BRIEF

    published on 04/30/2024 at 13:05, 2 years 4 months ago

    Emmecell achève le dosage final de la thérapie cellulaire dans le cadre d'un essai clinique américain sur l'œdème cornéen

    Thérapie Cellulaire Essai Clinique Emmecell Œdème Cornéen Traitement Non Chirurgical
  • PRESS RELEASE

    published on 04/30/2024 at 13:00, 2 years 4 months ago

    Emmecell Completes Final Cell Therapy Dosing in U.S. Clinical Trial for Corneal Edema

    Emmecell completes final dose administration for the last patient in U.S. trial for EO2002, a non-surgical cell therapy for corneal edema, showing promise for treating vision loss
    Clinical Trial Cell Therapy Emmecell Corneal Edema EO2002
    Logo of Emmecell
Accesswire
  • Published on 09/02/2026 at 18:45, 40 minutes ago

    Full Circle Lithium Rebrands as FCL-X Fire & Safety Inc. and Provides Corporate Update

  • Published on 09/02/2026 at 15:00, 4 hours 25 minutes ago

    Vox Royalty Enters into Binding Agreement to Acquire the White Dam Gold Royalty in Australia

  • Published on 09/02/2026 at 14:30, 4 hours 55 minutes ago

    Solitario Completes Phase-One Drilling at Golden Crest - Reports Initial Drill Results for Ponderosa

  • Published on 09/02/2026 at 14:00, 5 hours 25 minutes ago

    Orogen Royalties Acquires Two Gold Projects in Southwest Utah

  • Published on 09/02/2026 at 14:00, 5 hours 25 minutes ago

    Datametrex Plans to Focus on AI, Data Centre, and Patent Licensing

View all ACCESSWIRE
EQS Group
  • Published on 09/02/2026 at 19:00, 25 minutes ago

    PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF

  • Published on 09/02/2026 at 18:48, 37 minutes ago

    Original-Research: Rakovina Therapeutics Inc. (von First Berlin Equity Research GmbH): Add

  • Published on 09/02/2026 at 18:35, 50 minutes ago

    Holding(s) in Company

  • Published on 09/02/2026 at 18:30, 55 minutes ago

    RÉSULTAT DE L’ASSEMBLÉE GÉNÉRALE ORDINAIRE ET EXTRAORDINAIRE DU 2 SEPTEMBRE 2026

  • Published on 09/02/2026 at 18:15, 1 hour 10 minutes ago

    Haier Smart Home Co., Ltd. Launches Voluntary Public Share Buy-back Offer for up to 81,044,512 D-Shares at EUR 1.87

View all EQS
Les Echos
  • Published on 09/02/2026 at 19:03, 21 minutes ago

    Communiqué au dépôt du projet de note d'information établi par Bourrelier Group

  • Published on 09/02/2026 at 18:20, 1 hour 5 minutes ago

    Appointment to Edenred’s Executive Committee

  • Published on 09/02/2026 at 18:20, 1 hour 5 minutes ago

    Nomination au Comité exécutif d'Edenred

  • Published on 09/02/2026 at 18:00, 1 hour 25 minutes ago

    Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 31 août 2026

  • Published on 09/02/2026 at 18:00, 1 hour 25 minutes ago

    Outstanding shares and voting rights statement at 31 August 2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy